Shweta G.

Shweta G. has a diverse and extensive work history that spans various roles and industries. Shweta is currently employed as the Director of Operations at CymaBay Therapeutics, starting in February 2022. Prior to this, they held the position of Director Clinical Operations at Iovance Biotherapeutics, Inc. from September 2018 to April 2021. Shweta also worked as an Associate Director Clinical Operations at Acerta Pharma B.V. from June 2015 to August 2018. Additionally, they have experience as a Senior Clinical Trial Manager at Astex Pharmaceuticals from April 2014 to June 2015, and as a Clinical Trial Manager at both Astex and Teikoku Pharma USA from November 2012 to March 2014 and from April 2009 to November 2012, respectively. Shweta also had prior roles as a Clinical Research Associate at Teikoku Pharma USA and as an Intern at Stanford University. Shweta began their career as a Clinical Trials Student at the University of California, Santa Cruz. Before starting their career in the pharmaceutical industry, Shweta worked as a Program and Education Coordinator at the Ayurveda Institute of America and as an Associate Doctor at Dr. Ram Dharmadhikari Ayurvedic Clinic in Nagpur, India. Shweta'srole at the clinic involved treating chronic diseases under the mentorship of Dr. Ram Dharmadhikari, who has extensive experience in practicing and preaching Ayurveda.

Shweta G. has a diverse education history. Shweta obtained a Certificate in Clinical Trials Design and Management from the University of Santa Cruz in 2005 to 2006. Prior to that, from 1999 to 2002, they pursued an M.D. Degree in Ayurvedic Medicine from Shree Ayurvedic Mahavidyala in Nagpur, India. Earlier, from 1993 to 1998, they completed their B.A.M.S Degree in Ayurveda at Bhausaheb Mulak Ayurvedic Institute, also in Nagpur, India. Additionally, Shweta attended Dinanath High School for their high school education. Furthermore, they are fluent in English, Hindi, and Marathi languages.